Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 5
2012 4
2013 7
2014 6
2015 4
2016 9
2017 10
2018 16
2019 20
2020 16
2021 15
2022 12
2023 10
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Hyperthermic intraperitoneal chemotherapy in colorectal cancer.
Fisher OM, Brown C, Esquivel J, Larsen SG, Liauw W, Alzahrani NA, Morris DL, Kepenekian V, Sourrouille I, Dumont F, Tuech JJ, Ceribelli C, Doussot B, Sgarbura O, Alhosni M, Quenet F, Glehen O, Cashin PH; Peritoneal Surface Oncology Group International (PSOGI), Nordic Peritoneal Oncology Group (NPOG), American Society for Peritoneal Surface Malignancy (ASPSM) and BIG-RENAPE Groups. Fisher OM, et al. BJS Open. 2024 May 8;8(3):zrae017. doi: 10.1093/bjsopen/zrae017. BJS Open. 2024. PMID: 38722737 Free PMC article.
[CHIP and ovarian cancer].
Lécuru F, Bakrin N, Classe JM, Colombo PE, Ferron G, Freyer G, Glehen O, Gouy S, Huchon C, Narducci F, Pocard M, Pomel C, Rouzier R. Lécuru F, et al. Among authors: bakrin n. Gynecol Obstet Fertil Senol. 2019 Sep;47(9):617-618. doi: 10.1016/j.gofs.2019.06.007. Epub 2019 Jun 26. Gynecol Obstet Fertil Senol. 2019. PMID: 31252153 French. No abstract available.
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Koole S, van Stein R, Sikorska K, Barton D, Perrin L, Brennan D, Zivanovic O, Mosgaard BJ, Fagotti A, Colombo PE, Sonke G, Driel WJV; OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group. Koole S, et al. Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23. Int J Gynecol Cancer. 2020. PMID: 32205449 Free PMC article.
Review of 2022 PSOGI/RENAPE Consensus on HIPEC.
Kusamura S, Bhatt A, van Der Speeten K, Kepenekian V, Hübner M, Eveno C, de Hingh I, Delhorme JB, Taibi A, Villeneuve L, Dico RL, Moran B, Govaerts K, Zivanovic O, Brennan D, Nadeau C, Van Driel W, Bakrin N, Piso P, Verwaal VJ, González-Moreno S, Alyami M, Sgarbura O, Rau B, Deraco M, Glehen O. Kusamura S, et al. Among authors: bakrin n. J Surg Oncol. 2024 Sep 16. doi: 10.1002/jso.27885. Online ahead of print. J Surg Oncol. 2024. PMID: 39285659 Review.
Troponin measurement for risk stratification after cytoreductive surgery.
Vacheron CH, Lambert A, Fauvernier M, Vassal O, Wallet F, Bakrin N, Vaudoyer D, Kepenekian V, Passot G, Glehen O, Piriou V, Friggeri A. Vacheron CH, et al. Among authors: bakrin n. Br J Surg. 2021 Sep 27;108(9):e297-e298. doi: 10.1093/bjs/znab195. Br J Surg. 2021. PMID: 34136898 No abstract available.
Ovarian cancer in the older patient: where are we now? What to do next?
Rousseau F, Ranchon F, Bardin C, Bakrin N, Lavoué V, Bengrine-Lefevre L, Falandry C. Rousseau F, et al. Among authors: bakrin n. Ther Adv Med Oncol. 2023 Sep 16;15:17588359231192397. doi: 10.1177/17588359231192397. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37724138 Free PMC article. Review.
Advances in the management of peritoneal malignancies.
Kepenekian V, Bhatt A, Péron J, Alyami M, Benzerdjeb N, Bakrin N, Falandry C, Passot G, Rousset P, Glehen O. Kepenekian V, et al. Among authors: bakrin n. Nat Rev Clin Oncol. 2022 Nov;19(11):698-718. doi: 10.1038/s41571-022-00675-5. Epub 2022 Sep 7. Nat Rev Clin Oncol. 2022. PMID: 36071285 Review.
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial.
Classe JM, Meeus P, Hudry D, Wernert R, Quenet F, Marchal F, Houvenaeghel G, Bats AS, Lecuru F, Ferron G, Brigand C, Berton D, Gladieff L, Joly F, Ray-Coquard I, Durand-Fontanier S, Liberale G, Pocard M, Georgeac C, Gouy S, Guilloit JM, Guyon F, Costan C, Rousselet JM, de Guerké L, Bakrin N, Brument E, Martin E, Asselain B, Campion L, Glehen O; UNICANCER/CHIPOR Investigators. Classe JM, et al. Among authors: bakrin n. Lancet Oncol. 2024 Dec;25(12):1551-1562. doi: 10.1016/S1470-2045(24)00531-X. Epub 2024 Nov 14. Lancet Oncol. 2024. PMID: 39549720 Clinical Trial.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study.
Trecourt A, Bakrin N, Glehen O, Gertych W, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Genestie C, Dartigues P, Leroux A, Quenet F, Marchal F, Odin C, Khellaf L, Svrcek M, Thierry S, Augros M, Omar A, Devouassoux-Shisheboran M, Kepenekian V; RENAPE Group. Trecourt A, et al. Among authors: bakrin n. Ann Surg Oncol. 2024 May;31(5):3325-3338. doi: 10.1245/s10434-023-14850-0. Epub 2024 Feb 10. Ann Surg Oncol. 2024. PMID: 38341381 Free PMC article.
126 results